Elevated tenascin-c levels in bronchoalveolar lavage fluid of patients with sarcoidosis

Lung

Volumn 190, Issue 5, 2012, Pages 537-543

  Fujita, Hanako ^a   Sakamoto, Noriho ^a   Ishimatsu, Yuji ^a   Kakugawa, Tomoyuki ^a   Nakashima, Shota ^a   Hara, Shintaro ^a   Hara, Atsuko ^a   Mukae, Hiroshi ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Angiotensin converting enzyme; Biomarker; Extracellular matrix; Soluble interleukin 2 receptor; Tenascin C

Indexed keywords

LACTATE DEHYDROGENASE; TENASCIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SARCOIDOSIS; THORAX RADIOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LACTATE DEHYDROGENASES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TENASCIN;

EID: 84866743207     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9400-1     Document Type: Article

References (23)

1. Miyoshi S, Hamada H, Kadowaki T, Hamaguchi N, Ito R, Irifune K, Higaki J (2010) Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest 137:1391-1397
2. Morgenthau AS, Iannuzzi MC (2011) Recent advances in sarcoidosis. Chest 139:174-182
3. Baughman RP, Culver DA, Judson MA (2011) A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183:573-581
4. Baughman RP, Lower EE (2011) Who dies from sarcoidosis and why? Am J Respir Crit Care Med 183:1446-1447
5. Brellier F, Tucker RP, Chiquet-Ehrismann R (2009) Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports 19:511-519
6. Tucker RP, Chiquet-Ehrismann R (2009) The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 1793:888-892
7. Kaarteenaho-Wiik R, Mertaniemi P, Sajanti E, Soini Y, Paakko P (1998) Tenascin is increased in epithelial lining fluid in fibrotic lung disorders. Lung 176:371-380
8. Kaarteenaho-Wiik R, Sademies O, Paakko P, Risteli J, Soini Y (2007) Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung. Hum Pathol 38:147-153
9. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277-304
10. [No authors listed] (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adoptedbythe ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736-755
11. Sakamoto N, Mukae H, Fujii T, Kakugawa T, Kaida H, Kadota J, Kohno S (2004) Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1. Respir Med 98:213-219
12. Chiquet-Ehrismann R, Chiquet M (2003) Tenascins: regulation and putative functions during pathological stress. J Pathol 200: 488-499
13. Hisatomi K, Sakamoto N, Mukae H, Hayashi T, Amenomori M, Ishimoto H, Fujita H, Ishii H, Nakayama S, Ishimatsu Y, Kohno S (2009) Elevated levels of tenascin-C in patients with cryptogenic organizing pneumonia. Intern Med 48:1501-1507
14. Lofdahl M, Kaarteenaho R, Lappi-Blanco E, Tornling G, Skold MC (2011) Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respir Res 12:48
15. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA (1997) Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156:951-958
16. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Paakko P (1996) Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 154:511-518
17. Kuhn C, Mason RJ (1995) Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 147:1759-1769
18. Danila E, Jurgauskiene L, Norkuniene J, Malickaite R (2009) BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity. Ups J Med Sci 114:26-31
19. Clark RA, Erickson HP, Springer TA (1997) Tenascin supports lymphocyte rolling. J Cell Biol 137:755-765
20. Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS (1983) Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest 84:522-528
21. Prior C, Barbee RA, Evans PM, Townsend PJ, Primett ZS, Fyhrquist F, Gronhagen-Riska C, Haslam PL (1990) Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosis. Eur Respir J 3:1146-1154
22. Ainslie GM, Poulter LW, du Bois RM (1989) Relation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis. Thorax 44:501-509
23. Grutters JC (2003) Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 124:186-195